BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21438004)

  • 1. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
    Yan D; He Q; Chen Y; Wang L; Zhang X
    J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
    Ibrahim GH; Mahmoud MA; Aly NM
    Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
    Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
    Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
    Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
    Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.
    Tahon AM; El-Ghanam MZ; Zaky S; Emran TM; Bersy AM; El-Raey F; A Z E; El Kharsawy AM; Johar D
    J Gastrointest Cancer; 2019 Sep; 50(3):434-441. PubMed ID: 29623600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.
    Hagag NA; Ali YBM; Elsharawy AA; Talaat RM
    J Gastrointest Cancer; 2020 Mar; 51(1):234-241. PubMed ID: 31028536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.
    Li B; Liu H; Shang HW; Li P; Li N; Ding HG
    Afr Health Sci; 2013 Sep; 13(3):703-9. PubMed ID: 24250310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis.
    Sun B; Huang Z; Wang B; Yu Y; Lin S; Luo L; Wang Y; Huang Z
    Med Sci Monit; 2017 Feb; 23():850-855. PubMed ID: 28207681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
    Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
    Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-3 and Melanoma Antigen Genes 1 and 3 as Tumor Markers for Hepatocellular Carcinoma.
    El-Wahab NM; Rashed HG; El-Sherif WT; Sayed SK; Abd-Elmalek MO; Refaiy A; Fakhry H; Mokhtar AA
    Egypt J Immunol; 2017 Jun; 24(2):187-200. PubMed ID: 29708315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma.
    Liu H; Li P; Zhai Y; Qu CF; Zhang LJ; Tan YF; Li N; Ding HG
    World J Gastroenterol; 2010 Sep; 16(35):4410-5. PubMed ID: 20845507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.
    Xue R; Feng J; Meng Q; Lv F; Zhu Y; Yu H; Zhang S; Song C; Sun L; Yue Z; Feng S; Che R; Xiang Q; Jing X
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1503-1511. PubMed ID: 28087980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Wu W; Yan XD; Yu DD; Qiu LW; Yang JL; Zhang HJ; Sai WL; Chen J
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):171-9. PubMed ID: 23558072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.